AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 1-25/51
RELAPSE MARKERS IN MULTIPLE-SCLEROSIS - ARE IN-VITRO CYTOKINE PRODUCTION CHANGES REFLECTED BY CIRCULATORY T-CELL PHENOTYPE ALTERATIONS
Authors: DEBRUYNE J PHILIPPE J DEREUCK J WILLEMS A LEROUXROELS G
Citation: J. Debruyne et al., RELAPSE MARKERS IN MULTIPLE-SCLEROSIS - ARE IN-VITRO CYTOKINE PRODUCTION CHANGES REFLECTED BY CIRCULATORY T-CELL PHENOTYPE ALTERATIONS, Multiple sclerosis, 4(3), 1998, pp. 193-197
DETECTION OF NEW TTV GENOTYPE-2C, GENOTYPE-2D, GENOTYPE-3, AND GENOTYPE-4 IN BELGIAN PATIENTS WITH HEPATITIS OF UNKNOWN ETIOLOGY
Authors: DEVREESE K DUCATTEEUW A DEPLA E PRIEM S LEROUXROELS G DEGROOTE G MAERTENS G
Citation: K. Devreese et al., DETECTION OF NEW TTV GENOTYPE-2C, GENOTYPE-2D, GENOTYPE-3, AND GENOTYPE-4 IN BELGIAN PATIENTS WITH HEPATITIS OF UNKNOWN ETIOLOGY, Hepatology, 28(4), 1998, pp. 526-526
INFLUENCE OF THE CYS282TYR MUTATION AND HAPTOGLOBIN POLYMORPHISM ON IRON-METABOLISM IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: VANVLIERBERGHE CH MESSIAEN L DELANGHE JR HAUTEKEETE M DEPAEPE A LEROUXROELS G ELEWAUT A
Citation: Ch. Vanvlierberghe et al., INFLUENCE OF THE CYS282TYR MUTATION AND HAPTOGLOBIN POLYMORPHISM ON IRON-METABOLISM IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 28(4), 1998, pp. 1221-1221
RESPONSE TO HEPATITIS-B VACCINE - MULTIPLE HLA GENES ARE INVOLVED
Authors: DESOMBERE I WILLEMS A LEROUXROELS G
Citation: I. Desombere et al., RESPONSE TO HEPATITIS-B VACCINE - MULTIPLE HLA GENES ARE INVOLVED, Hepatology, 28(4), 1998, pp. 1270-1270
PARTIAL DELIPIDATION IMPROVES THE T-CELL IMMUNOGENICITY OF HEPATITIS-B SURFACE-ANTIGEN
Authors: DESOMBERE I LEROUXROELS G WETTENDORF M WILLEMS A GIJBELS Y VERWULGEN A
Citation: I. Desombere et al., PARTIAL DELIPIDATION IMPROVES THE T-CELL IMMUNOGENICITY OF HEPATITIS-B SURFACE-ANTIGEN, Hepatology, 28(4), 1998, pp. 2219-2219
SAFETY AND IMMUNOGENICITY OF A HEPATITIS-B VACCINE FORMULATED WITH A NOVEL ADJUVANT SYSTEM
Authors: THOELEN S VANDAMME P MATHEI C LEROUXROELS G DESOMBERE I SAFARY A VANDEPAPELIERE P SLAOUI M MEHEUS A
Citation: S. Thoelen et al., SAFETY AND IMMUNOGENICITY OF A HEPATITIS-B VACCINE FORMULATED WITH A NOVEL ADJUVANT SYSTEM, Vaccine, 16(7), 1998, pp. 708-714
ULTRARAPID HEPATITIS-C VIRUS CLEARANCE BY DAILY HIGH-DOSE INTERFERON IN NONRESPONDERS TO STANDARD THERAPY
Authors: BEKKERING FC BROUWER JT LEROUXROELS G VANVLIERBERGHE H ELEWAUT A SCHALM SW
Citation: Fc. Bekkering et al., ULTRARAPID HEPATITIS-C VIRUS CLEARANCE BY DAILY HIGH-DOSE INTERFERON IN NONRESPONDERS TO STANDARD THERAPY, Journal of hepatology, 28(6), 1998, pp. 960-964
HBV-SPECIFIC LYMPHOPROLIFERATIVE AND CYTOKINE RESPONSES IN PATIENTS WITH CHRONIC HEPATITIS-B
Authors: VINGERHOETS J MICHIELSEN P VANHAM G BOSMANS E PAULIJ W RAMON A PELCKMANS P KESTENS L LEROUXROELS G
Citation: J. Vingerhoets et al., HBV-SPECIFIC LYMPHOPROLIFERATIVE AND CYTOKINE RESPONSES IN PATIENTS WITH CHRONIC HEPATITIS-B, Journal of hepatology, 28(1), 1998, pp. 8-16
MURINE IL-2 RECEPTOR-BETA CHAIN BLOCKADE IMPROVES HUMAN-LEUKOCYTE ENGRAFTMENT IN SCID MICE
Authors: TOURNOY KG DEPRAETERE S MEULEMAN P LEROUXROELS G PAUWELS RA
Citation: Kg. Tournoy et al., MURINE IL-2 RECEPTOR-BETA CHAIN BLOCKADE IMPROVES HUMAN-LEUKOCYTE ENGRAFTMENT IN SCID MICE, European Journal of Immunology, 28(10), 1998, pp. 3221-3230
RESPONSE TO HEPATITIS-B VACCINE - MULTIPLE HLA GENES ARE INVOLVED
Authors: DESOMBERE I WILLEMS A LEROUXROELS G
Citation: I. Desombere et al., RESPONSE TO HEPATITIS-B VACCINE - MULTIPLE HLA GENES ARE INVOLVED, Tissue antigens, 51(6), 1998, pp. 593-604
COMBINATION HEPATITIS-A HEPATITIS-B VACCINE - A VIEWPOINT
Authors: LEROUXROELS G
Citation: G. Lerouxroels, COMBINATION HEPATITIS-A HEPATITIS-B VACCINE - A VIEWPOINT, Biodrugs, 8(3), 1997, pp. 240-240
DISTRIBUTION OF LYMPHOCYTE SUBSETS IN BONE-MARROW AND PERIPHERAL-BLOOD IS ASSOCIATED WITH HAPTOGLOBIN TYPE - BINDING OF HAPTOGLOBIN TO THE B-CELL LECTIN CD22
Authors: LANGLOIS M DELANGHE J PHILIPPE J OUYANG J BERNARD D DEBUYZERE M VANNOOTEN G LEROUXROELS G
Citation: M. Langlois et al., DISTRIBUTION OF LYMPHOCYTE SUBSETS IN BONE-MARROW AND PERIPHERAL-BLOOD IS ASSOCIATED WITH HAPTOGLOBIN TYPE - BINDING OF HAPTOGLOBIN TO THE B-CELL LECTIN CD22, European journal of clinical chemistry and clinical biochemistry, 35(3), 1997, pp. 199-205
IS ANGIOTENSIN-CONVERTING ENZYME I D POLYMORPHISM INVOLVED IN CARDIOVASCULAR COMPLICATIONS IN ESSENTIAL-HYPERTENSION/
Authors: DEBUYZERE ML WUYTS BB DELANGHE JR DUPREZ DA LEROUXROELS G
Citation: Ml. Debuyzere et al., IS ANGIOTENSIN-CONVERTING ENZYME I D POLYMORPHISM INVOLVED IN CARDIOVASCULAR COMPLICATIONS IN ESSENTIAL-HYPERTENSION/, Journal of the American College of Cardiology, 29(2), 1997, pp. 7241-7241
ANTIBODIES TO E1 AND E2 IN PATIENTS INFECTED WITH HCV 1B - EVOLUTION OF ANTIBODY-LEVELS AFTER INTERFERON THERAPY
Authors: DEPRAETERE S VANKERSCHAVER E ELEWAUT A BROUWER J NIESTERS B SCHALM S MAERTENS G LEROUXROELS G
Citation: S. Depraetere et al., ANTIBODIES TO E1 AND E2 IN PATIENTS INFECTED WITH HCV 1B - EVOLUTION OF ANTIBODY-LEVELS AFTER INTERFERON THERAPY, Hepatology, 26(4), 1997, pp. 338-338
ANTIBODIES TO E1 AND E2 IN CHRONIC HCV PATIENTS WITH A LONG-TERM RESPONSE TO INTERFERON THERAPY
Authors: DEPRAETERE S VANKERSCHAVER E VANVLIERBERGHE H ELEWAUT A DEPLA E MAERTENS G LEROUXROELS G
Citation: S. Depraetere et al., ANTIBODIES TO E1 AND E2 IN CHRONIC HCV PATIENTS WITH A LONG-TERM RESPONSE TO INTERFERON THERAPY, Hepatology, 26(4), 1997, pp. 717-717
ANTIBODIES TO E1 AND E2 IN PATIENTS INFECTED WITH HCV 1B - CORRELATION WITH RESPONSE TO INTERFERON THERAPY
Authors: DEPRAETERE S VANKERSCHAVER E ELEWAUT A BROUWER J NIESTERS B SCHALM S MAERTENS G LEROUXROELS G
Citation: S. Depraetere et al., ANTIBODIES TO E1 AND E2 IN PATIENTS INFECTED WITH HCV 1B - CORRELATION WITH RESPONSE TO INTERFERON THERAPY, Hepatology, 26(4), 1997, pp. 718-718
INTERLEUKIN-12 INDUCES RESPONSES TO HBSAG IN CHRONIC HBV CARRIERS
Authors: VINGERHOETS J MICHIELSEN P VANHAM G KESTENS L BOSMANS E PAULIJ W RAMON A PELCKMANS P LEROUXROELS G
Citation: J. Vingerhoets et al., INTERLEUKIN-12 INDUCES RESPONSES TO HBSAG IN CHRONIC HBV CARRIERS, Hepatology, 26(4), 1997, pp. 767-767
PREVALENCE OF GBV-C HGV AND NEW HCV MARKERS IN HEALTHY, VOLUNTARY BLOOD-DONORS WITH ELEVATED ALT LEVELS OF UNKNOWN ORIGIN/
Authors: ROOBROUCK A DEPRAETERE S COUVENT S VANKERSCHAVER E VANDURME H VANDEKERCKHOVE B MAERTENS G DEKEYSER F STOOPS E ZREIN M LEROUXROELS G
Citation: A. Roobrouck et al., PREVALENCE OF GBV-C HGV AND NEW HCV MARKERS IN HEALTHY, VOLUNTARY BLOOD-DONORS WITH ELEVATED ALT LEVELS OF UNKNOWN ORIGIN/, Hepatology, 26(4), 1997, pp. 792-792
ULTRARAPID HEPATITIS-C VIRUS CLEARANCE BY DAILY HIGH-DOSE INTERFERON IN NONRESPONDERS TO STANDARD THERAPY
Authors: BEKKERING FC BROUWER JT LEROUXROELS G VANVLIERBERGHE H ELEWAUT A SCHALM SW
Citation: Fc. Bekkering et al., ULTRARAPID HEPATITIS-C VIRUS CLEARANCE BY DAILY HIGH-DOSE INTERFERON IN NONRESPONDERS TO STANDARD THERAPY, Hepatology, 26(4), 1997, pp. 1147-1147
PREVALENCE OF GBV-C HGV AND HCV IN 4 HEMODIALYSIS UNITS IN FLANDERS (BELGIUM)/
Authors: ROOBROUCK A DEPRAETERE S COUVENT S VANKERSCHAVER E MAERTENS G LEROUXROELS G
Citation: A. Roobrouck et al., PREVALENCE OF GBV-C HGV AND HCV IN 4 HEMODIALYSIS UNITS IN FLANDERS (BELGIUM)/, Hepatology, 26(4), 1997, pp. 1850-1850
EARLY DISAPPEARANCE OF HCV RNA IS A PROGNOSTIC MARKER OF SUSTAINED RESPONSE DURING RETREATMENT OF HEPATITIS-C NON SUSTAINED RESPONDERS
Authors: VANVLIERBERGHE H ELEWAUT AE BEKKERING FC BROUWER JT LEROUXROELS G SCHALM SW ELEWAUT A
Citation: H. Vanvlierberghe et al., EARLY DISAPPEARANCE OF HCV RNA IS A PROGNOSTIC MARKER OF SUSTAINED RESPONSE DURING RETREATMENT OF HEPATITIS-C NON SUSTAINED RESPONDERS, Hepatology, 26(4), 1997, pp. 1970-1970
HEPATITIS-B VACCINE CONTAINING SURFACE-ANTIGEN AND SELECTED PRES1 ANDPRES2 SEQUENCES .1. SAFETY AND IMMUNOGENICITY IN YOUNG, HEALTHY-ADULTS
Authors: LEROUXROELS G DESOMBERE I DETOLLENAERE G PETIT MA DESMONS P HAUSER P DELEM A DEGRAVE D SAFARY A
Citation: G. Lerouxroels et al., HEPATITIS-B VACCINE CONTAINING SURFACE-ANTIGEN AND SELECTED PRES1 ANDPRES2 SEQUENCES .1. SAFETY AND IMMUNOGENICITY IN YOUNG, HEALTHY-ADULTS, Vaccine, 15(16), 1997, pp. 1724-1731
HEPATITIS-B VACCINE CONTAINING SURFACE-ANTIGEN AND SELECTED PRES1 ANDPRES2 SEQUENCES .2. IMMUNOGENICITY IN POOR RESPONDERS TO HEPATITIS-B VACCINES
Authors: LEROUXROELS G DESOMBERE I COBBAUT L PETIT MA DESMONS P HAUSER P DELEM A DEGRAVE D SAFARY A
Citation: G. Lerouxroels et al., HEPATITIS-B VACCINE CONTAINING SURFACE-ANTIGEN AND SELECTED PRES1 ANDPRES2 SEQUENCES .2. IMMUNOGENICITY IN POOR RESPONDERS TO HEPATITIS-B VACCINES, Vaccine, 15(16), 1997, pp. 1732-1736
IN-VITRO TNF-ALPHA, IL-2 AND IFN-GAMMA PRODUCTION AS MARKERS OF RELAPSES IN MULTIPLE-SCLEROSIS
Authors: PHILIPPE J DEBRUYNE J LEROUXROELS G WILLEMS A DEREUCK J
Citation: J. Philippe et al., IN-VITRO TNF-ALPHA, IL-2 AND IFN-GAMMA PRODUCTION AS MARKERS OF RELAPSES IN MULTIPLE-SCLEROSIS, Clinical neurology and neurosurgery, 98(4), 1996, pp. 286-290
COMPARISON OF A RECOMBINANT THROMBOPLASTIN WITH THROMBOTEST(TM) FOR ORAL ANTICOAGULANT CONTROL
Authors: BAELE G FIERS T LEROUXROELS G
Citation: G. Baele et al., COMPARISON OF A RECOMBINANT THROMBOPLASTIN WITH THROMBOTEST(TM) FOR ORAL ANTICOAGULANT CONTROL, Haemostasis, 26(1), 1996, pp. 11-15
Risultati: 1-25 | 26-50 | 51-51